E Pisi

6.0k total citations · 1 hit paper
125 papers, 3.8k citations indexed

About

E Pisi is a scholar working on Epidemiology, Hepatology and Physiology. According to data from OpenAlex, E Pisi has authored 125 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Epidemiology, 63 papers in Hepatology and 18 papers in Physiology. Recurrent topics in E Pisi's work include Liver Disease Diagnosis and Treatment (56 papers), Liver Disease and Transplantation (36 papers) and Celiac Disease Research and Management (16 papers). E Pisi is often cited by papers focused on Liver Disease Diagnosis and Treatment (56 papers), Liver Disease and Transplantation (36 papers) and Celiac Disease Research and Management (16 papers). E Pisi collaborates with scholars based in Italy, France and United States. E Pisi's co-authors include Giulio Marchesini, Marco Zoli, Francesco B. Bianchi, Giampaolo Bianchi, Giorgio Ballardini, Rita Mirakian, Andrea Fabbri, Deborah Doniach, GianFranco Bottazzo and Donatella Magalotti and has published in prestigious journals such as Nature, The Lancet and Gastroenterology.

In The Last Decade

E Pisi

123 papers receiving 3.7k citations

Hit Papers

ABERRANT EXPRESSION OF HLA-DR ANTIGENS ON BILEDUCT EPITHE... 1984 2026 1998 2012 1984 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Pisi Italy 34 2.2k 2.2k 776 450 413 125 3.8k
Kyuichi Tanikawa Japan 39 2.5k 1.1× 2.2k 1.0× 1.3k 1.7× 324 0.7× 763 1.8× 201 4.8k
Siegfried Matern Germany 34 1.1k 0.5× 1.2k 0.6× 1.1k 1.4× 235 0.5× 617 1.5× 79 3.8k
Prithi S. Bhathal Australia 35 1.6k 0.7× 3.1k 1.4× 1.7k 2.2× 543 1.2× 1.0k 2.4× 122 6.1k
Hitoshi Takagi Japan 32 1.5k 0.7× 1.3k 0.6× 963 1.2× 142 0.3× 649 1.6× 212 3.5k
Massimo Zuin Italy 39 2.5k 1.1× 2.3k 1.1× 1.2k 1.6× 128 0.3× 309 0.7× 142 4.2k
Hiroyuki Kirikoshi Japan 36 936 0.4× 2.1k 1.0× 993 1.3× 298 0.7× 1.2k 2.8× 138 4.0k
Maha Guindi Canada 34 1.9k 0.9× 2.1k 1.0× 1.2k 1.6× 189 0.4× 505 1.2× 115 3.9k
Claudio Avellini Italy 36 863 0.4× 1.2k 0.5× 1.6k 2.0× 313 0.7× 483 1.2× 115 3.7k
Fabio Maria Vecchio Italy 36 765 0.3× 1.5k 0.7× 1.7k 2.1× 538 1.2× 1.0k 2.5× 130 5.0k
Harvey L. Sharp United States 36 844 0.4× 749 0.3× 1.7k 2.1× 501 1.1× 832 2.0× 138 4.6k

Countries citing papers authored by E Pisi

Since Specialization
Citations

This map shows the geographic impact of E Pisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Pisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Pisi more than expected).

Fields of papers citing papers by E Pisi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Pisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Pisi. The network helps show where E Pisi may publish in the future.

Co-authorship network of co-authors of E Pisi

This figure shows the co-authorship network connecting the top 25 collaborators of E Pisi. A scholar is included among the top collaborators of E Pisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Pisi. E Pisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mitri, Maria Stella De, Giulia Morsica, Giovanni Sitia, et al.. (2000). Effect of increasing dose of interferon on the evolution of hepatitis C virus 1b quasispecies. Journal of Medical Virology. 60(2). 133–138. 6 indexed citations
2.
Mitri, Maria Stella De, E Pisi, Karine Poussin, et al.. (1995). HCV-associated liver cancer without cirrhosis. The Lancet. 345(8947). 413–415. 228 indexed citations
3.
Bonfiglioli, Roberta, et al.. (1994). A new risk of occupational disease: allergic asthma and rhinoconjunctivitis in persons working with beneficial arthropods. International Archives of Occupational and Environmental Health. 65(5). 291–294. 10 indexed citations
4.
Paterlini-Bréchot, Patrizia, Françoise Driss, Bertrand Nalpas, et al.. (1993). Persistence of Hepatitis B and Hepatitis C Viral Genomes in Primary Liver Cancers from HBsAg-Negative Patients: A Study of a Low-endemic Area. Hepatology. 17(1). 20–29. 162 indexed citations
5.
Marchesini, Giulio, Elisabetta Bugianesi, Giampaolo Bianchi, et al.. (1992). Defective Methionine Metabolism in Cirrhosis: Relation to Severity of Liver Disease. Hepatology. 16(1). 149–155. 51 indexed citations
6.
Zoli, Marco, et al.. (1990). Ultrasonographic follow‐up of liver cirrhosis. Journal of Clinical Ultrasound. 18(2). 91–96. 19 indexed citations
7.
Marchesini, Giulio, Giampaolo Bianchi, Andrea Fabbri, et al.. (1990). Synthesis of Urea after a Protein-rich Meal in Normal Man in Relation to Ageing. Age and Ageing. 19(1). 4–10. 15 indexed citations
8.
Paterlini-Bréchot, Patrizia, G Gerken, W. Grigioni, et al.. (1990). HBV DNA and RNA sequences in HBsAg negative primary liver cancer. Detection by Polymerase chain reaction and relation to hepatitis C virus status. Journal of Hepatology. 11. S48–S48. 1 indexed citations
9.
Zoli, Marco, et al.. (1989). Portal Blood Velocity and Flow in Aging Man. Gerontology. 35(2-3). 61–65. 48 indexed citations
10.
11.
Volta, Umberto, et al.. (1988). Immunoglobulin A Antigliadin Antibodies in Jejunal Juice: Markers of Severe Intestinal Damage in Coeliac Children. Digestion. 39(1). 35–39. 7 indexed citations
12.
Marchesini, Giulio, Giovanni Antonio Checchia, Gabriele Grossi, et al.. (1988). Caffeine intake, fasting plasma caffeine and caffeine clearance in patients with liver diseases. Liver International. 8(4). 241–246. 9 indexed citations
13.
Volta, Umberto, et al.. (1987). IgA antibodies to dietary antigens in liver cirrhosis. La Ricerca in Clinica e in Laboratorio. 17(3). 235–242. 34 indexed citations
14.
Ballardini, Giorgio, Francesco B. Bianchi, Rita Mirakian, et al.. (1987). HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease.. PubMed. 70(1). 35–46. 42 indexed citations
15.
Zauli, Daniela, Cristina Crespi, Francesco B. Bianchi, & E Pisi. (1985). Immunofluorescent detection of anti-cytoskeleton antibodies using vinblastine-treated mononuclear cells. Journal of Immunological Methods. 82(1). 77–82. 11 indexed citations
16.
Zauli, Daniela, Cristina Crespi, Antonia Mancini, et al.. (1985). Relationship between Smooth Muscle and Cytoskeleton Antibodies in Neuroblastoma. Tumori Journal. 71(5). 425–430. 2 indexed citations
17.
Forlani, G, et al.. (1984). The Euglycemic Clamp Technique in Patients with Liver Cirrhosis. Hormone and Metabolic Research. 16(7). 341–343. 18 indexed citations
18.
Marchesini, Giulio, et al.. (1982). [Blood glucose and glucoregulatory hormones in liver cirrhosis: a study of 24 hour profiles and of the role of portal-systemic shunting].. PubMed. 6(3). 272–8. 8 indexed citations
19.
Marchesini, Giulio, Gabriele Forlani, Marco Zoli, et al.. (1979). Oral glucose in cirrhotics. Effects on plasma aminoacid patterns and the role of insulin and glucagon.. PubMed. 5(2). 135–9. 7 indexed citations
20.
Pisi, E, et al.. (1954). [Carcinogenic factors in relation to heterologous transplantation of human tumors].. PubMed. 31(4). 270–83. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026